Pharmaceutical Products for CDER Research Studies - IDIQ 75F40126Q132721
Summary
AI-generated · May 02, 2026Supply pharmaceutical products for CDER research studies under an Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract. Full requirements, scope, and evaluation criteria are described in the attached combined synopsis/solicitation.
See attached combined synopsis/solicitation.
From Combined Synopsis/Solicitation posted on May 01, 20265/4/2026: See attached amendment 1 which updates the SBCX link for the subcontracting plan. See attached combined synopsis/solicitation.
From Combined Synopsis/Solicitation posted on May 04, 2026Notice history
2-
-
Combined Synopsis/Solicitation LATEST Posted May 04, 2026View changes (1)
- Description: Description was updated
Details
Award Information
Not yet awarded
Contacts
Phone
Agency
Place of Performance
USA